Lupus Clinical Trial
Official title:
Predictors of Adaptation and a Cognitive Behavioral Intervention for African American Adolescents With Lupus
Verified date | May 2018 |
Source | Medical University of South Carolina |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate a program designed to help African American adolescents with lupus (systemic lupus erythematosus or SLE) cope with the disease.
Status | Completed |
Enrollment | 120 |
Est. completion date | April 2007 |
Est. primary completion date | April 2007 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of systemic lupus erythematosus (SLE) Exclusion Criteria: - Severe depression with suicidal thoughts - Delirium, dementia, or cognitive impairment (e.g., Mini Mental Status Examination 24 or less) - Severe intellectual impairment - Terminal illness with a life expectancy of less than 1 year |
Country | Name | City | State |
---|---|---|---|
United States | Ronald T. Brown, PhD | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Medical University of South Carolina | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BASC scores (measures of general adjustment) | 4 years | ||
Primary | BASS Scores | 4 years | ||
Primary | SPPA scores (perception of physical appearance and social | 4 years | ||
Primary | competence) | 4 years | ||
Primary | Peds-QL 4.0 and 3.0 (quality of life assessments) | 4 years | ||
Primary | Psychological Adjustment | 4 years | ||
Primary | BASC Scores | 4 years | ||
Secondary | SLEDAI (measure of disease status) | 4 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013995 -
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
|
Phase 1 | |
Recruiting |
NCT03952624 -
Patient-Centered Assessment of Symptoms and Outcomes
|
||
Terminated |
NCT01389895 -
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
|
Phase 1 | |
Completed |
NCT00710021 -
Vitamin D3 in Systemic Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT02265744 -
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
|
Phase 2 | |
Recruiting |
NCT06445127 -
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
|
N/A | |
Completed |
NCT00581763 -
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
|
N/A | |
Recruiting |
NCT01172002 -
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
|
N/A | |
Completed |
NCT00299819 -
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
Completed |
NCT00054938 -
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
|
Phase 2 | |
Terminated |
NCT03953690 -
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
|
||
Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
Enrolling by invitation |
NCT05321108 -
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus
|
N/A | |
Completed |
NCT00482989 -
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
Completed |
NCT00657189 -
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
|
Phase 2 | |
Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
Completed |
NCT03402087 -
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
|
Phase 1 | |
Completed |
NCT02857452 -
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
|
N/A | |
Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
Recruiting |
NCT05922722 -
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
|